Luo Z, Tzivion G, Belshaw P J, Vavvas D, Marshall M, Avruch J
Diabetes Unit and Medical Services, Massachusetts General Hospital, Boston 02129, USA.
Nature. 1996 Sep 12;383(6596):181-5. doi: 10.1038/383181a0.
The c-Raf-1 proto-oncoprotein is a Ras-GTP-regulated protein kinase that associates in situ with 14-3-3 proteins, which are naturally dimeric. In COS cells, recombinant Raf is found in oligomeric assemblies. To examine whether induced oligomerization can alter Raf kinase activity, sequences encoding the FK506-binding protein FKBP12 were fused to the amino terminus of c-Raf-1, introducing a binding site for FK506. Oligomerization of recombinant FKBP-Raf in situ, induced by the addition of the dimeric FK506 derivative FK1012A, activated Raf kinase activity at least half as well as epidermal growth factor (EGF). As with EGF, activation of FKBP-Raf by FK1012A is entirely Ras-GTP dependent. Thus oligomerization of Raf per se promotes Raf activation through a Ras-dependent mechanism.
原癌蛋白c-Raf-1是一种受Ras-GTP调节的蛋白激酶,它在原位与天然为二聚体的14-3-3蛋白结合。在COS细胞中,重组Raf存在于寡聚体组装物中。为了研究诱导寡聚化是否会改变Raf激酶活性,将编码FK506结合蛋白FKBP12的序列融合到c-Raf-1的氨基末端,引入了一个FK506结合位点。通过添加二聚体FK506衍生物FK1012A诱导重组FKBP-Raf在原位寡聚化,其激活Raf激酶活性的效果至少与表皮生长因子(EGF)一样好。与EGF一样,FK1012A对FKBP-Raf的激活完全依赖于Ras-GTP。因此,Raf本身的寡聚化通过一种依赖于Ras的机制促进Raf激活。